BENJAMIN JAGGERS: Open Payments
NPI 1982957221 · IOWA CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 24 payments from 11 companies in 2025. Trend: 2023 $370 · 2024 $322 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $167 |
| Neurocrine BioSciences, Inc. | 1 | $118 |
| Corium, LLC | 5 | $69 |
| Alkermes, Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $37 |
| Lundbeck LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Neuronetics, Inc. | 1 | $20 |
Products named: CAPLYTA, INGREZZA, Azstarys, REXULTI, ARISTADA, VRAYLAR, Auvelity, TRINTELLIX.
Industry payments across IA — which companies pay providers there.
